• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MCK

MCK

McKesson Corporation

NYSEHealthcareMedical - DistributionUS

USD739.53

+2.75 (+0.37%)

Rating:B-

Company Profile

CEO

Brian S. Tyler

IPO Date

1994-11-10

Sector

Healthcare

Industry

Medical - Distribution

Exchange

NYSE

Country

US

Market Metrics

Open

$740.17

Prev. Close

$736.78

Day Low

$729.35

Day High

$743.28

52W Low

$637.00

52W High

$999.00

Market Cap

$88.89B

Volume

0.56M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

49.9%

Avg Negative

10.9%

Avg Neutral

39.2%

News Feed

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

zacks.com·5/22/2026·↓ negative

McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com·5/12/2026·↑ positive

McKesson Q4 Earnings Call Highlights

marketbeat.com·5/11/2026·↑ positive

MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up

zacks.com·5/8/2026·↑ positive

McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript

seekingalpha.com·5/7/2026·↓ negative

Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics

zacks.com·5/7/2026·↑ positive

McKesson (MCK) Surpasses Q4 Earnings Estimates

zacks.com·5/7/2026·↑ positive

McKesson expects 2027 profit slightly above estimates on drug distribution strength

reuters.com·5/7/2026·↑ positive

McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

businesswire.com·5/7/2026·↓ negative

Should You Buy, Sell, or Hold McKesson Before Q4 Earnings?

zacks.com·5/7/2026·↑ positive